Ghazaleh Tabatabai
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Meningioma and schwannoma management, Brain Metastases and Treatment, Cancer, Hypoxia, and Metabolism, Immunotherapy and Immune Responses
Most-Cited Works
- → Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial(2012)1,112 cited
- → Actively personalized vaccination trial for newly diagnosed glioblastoma(2018)910 cited
- → EANO guideline on the diagnosis and management of meningiomas(2021)669 cited
- → Longitudinal molecular trajectories of diffuse glioma in adults(2019)578 cited
- → Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial(2019)568 cited
- → Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial(2022)452 cited
- → A clinically applicable integrative molecular classification of meningiomas(2021)432 cited
- → A vaccine targeting mutant IDH1 in newly diagnosed glioma(2021)411 cited
- → Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs(2013)376 cited
- → MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial(2015)314 cited